Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Zolinza (vorinostat)
i
Other names:
MSK-390, MSK390, MK 0683, L001079038, L 001079038, MSK 390, MK-0683, SAHA, MK0683, L-001079038
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(19)
News
Trials
Company:
Merck (MSD)
Drug class:
HDAC inhibitor
Related drugs:
‹
chidamide (23)
panobinostat (15)
romidepsin (9)
entinostat (9)
CUDC-907 (8)
OKI-179 (4)
SB939 (4)
belinostat (2)
CG-781 (2)
MGCD0103 (2)
REC-2282 (1)
4SC-202 (1)
JNJ 26481585 (1)
CUDC-101 (0)
givinostat (0)
resminostat (0)
RG2833 (0)
sulforafan alfadex (0)
CKD-581 (0)
histone deacetylase inhibitors/hypomethylating agents (0)
CG-745 (0)
kt-3000 series (0)
kt-3283 (0)
VRx-3996 (0)
MTX110 (0)
SHP-141 (0)
OBP-801 (0)
EDO-S101 (0)
VTR-297 (0)
CXD101 (0)
chidamide (23)
panobinostat (15)
romidepsin (9)
entinostat (9)
CUDC-907 (8)
OKI-179 (4)
SB939 (4)
belinostat (2)
CG-781 (2)
MGCD0103 (2)
REC-2282 (1)
4SC-202 (1)
JNJ 26481585 (1)
CUDC-101 (0)
givinostat (0)
resminostat (0)
RG2833 (0)
sulforafan alfadex (0)
CKD-581 (0)
histone deacetylase inhibitors/hypomethylating agents (0)
CG-745 (0)
kt-3000 series (0)
kt-3283 (0)
VRx-3996 (0)
MTX110 (0)
SHP-141 (0)
OBP-801 (0)
EDO-S101 (0)
VTR-297 (0)
CXD101 (0)
›
Associations
(19)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Cutaneous T-cell Lymphoma
No biomarker
Cutaneous T-cell Lymphoma
vorinostat
Sensitive: A1 - Approval
vorinostat
Sensitive
:
A1
vorinostat
Sensitive: A1 - Approval
vorinostat
Sensitive
:
A1
GNAQ mutation
Melanoma
GNAQ mutation
Melanoma
vorinostat
Sensitive: C2 – Inclusion Criteria
vorinostat
Sensitive
:
C2
vorinostat
Sensitive: C2 – Inclusion Criteria
vorinostat
Sensitive
:
C2
GNA11 mutation
Melanoma
GNA11 mutation
Melanoma
vorinostat
Sensitive: C2 – Inclusion Criteria
vorinostat
Sensitive
:
C2
vorinostat
Sensitive: C2 – Inclusion Criteria
vorinostat
Sensitive
:
C2
BAP1 mutation
Melanoma
BAP1 mutation
Melanoma
vorinostat
Sensitive: C2 – Inclusion Criteria
vorinostat
Sensitive
:
C2
vorinostat
Sensitive: C2 – Inclusion Criteria
vorinostat
Sensitive
:
C2
KMT2A-PTD
Acute Myelogenous Leukemia
KMT2A-PTD
Acute Myelogenous Leukemia
cytarabine + decitabine + vorinostat
Sensitive: C3 – Early Trials
cytarabine + decitabine + vorinostat
Sensitive
:
C3
cytarabine + decitabine + vorinostat
Sensitive: C3 – Early Trials
cytarabine + decitabine + vorinostat
Sensitive
:
C3
BRAF V600
Melanoma
BRAF V600
Melanoma
vorinostat
Sensitive: C3 – Early Trials
vorinostat
Sensitive
:
C3
vorinostat
Sensitive: C3 – Early Trials
vorinostat
Sensitive
:
C3
RNASET2 overexpression
Clear Cell Renal Cell Carcinoma
RNASET2 overexpression
Clear Cell Renal Cell Carcinoma
vorinostat
Sensitive: C3 – Early Trials
vorinostat
Sensitive
:
C3
vorinostat
Sensitive: C3 – Early Trials
vorinostat
Sensitive
:
C3
KMT2A rearrangement
B Acute Lymphoblastic Leukemia
KMT2A rearrangement
B Acute Lymphoblastic Leukemia
bortezomib + vorinostat + dexamethasone + mitoxantrone
Sensitive: C3 – Early Trials
bortezomib + vorinostat + dexamethasone + mitoxantrone
Sensitive
:
C3
bortezomib + vorinostat + dexamethasone + mitoxantrone
Sensitive: C3 – Early Trials
bortezomib + vorinostat + dexamethasone + mitoxantrone
Sensitive
:
C3
RAD23B overexpression
Soft Tissue Sarcoma
RAD23B overexpression
Soft Tissue Sarcoma
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
SOCS1 overexpression
Hepatocellular Cancer
SOCS1 overexpression
Hepatocellular Cancer
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
GSTP1 overexpression
Hepatocellular Cancer
GSTP1 overexpression
Hepatocellular Cancer
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
HDAC1 underexpression
Hepatocellular Cancer
HDAC1 underexpression
Hepatocellular Cancer
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
RET L629P
Head and Neck Cancer
RET L629P
Head and Neck Cancer
vorinostat + ABT-737
Sensitive: D – Preclinical
vorinostat + ABT-737
Sensitive
:
D
vorinostat + ABT-737
Sensitive: D – Preclinical
vorinostat + ABT-737
Sensitive
:
D
FBXW7 deletion
Squamous Cell Carcinoma of Head and Neck
FBXW7 deletion
Squamous Cell Carcinoma of Head and Neck
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
EGFR C797S + EGFR T790M + EGFR L858R
Lung Adenocarcinoma
EGFR C797S + EGFR T790M + EGFR L858R
Lung Adenocarcinoma
brigatinib + vorinostat
Sensitive: D – Preclinical
brigatinib + vorinostat
Sensitive
:
D
brigatinib + vorinostat
Sensitive: D – Preclinical
brigatinib + vorinostat
Sensitive
:
D
MYB-TYK2 fusion
B Acute Lymphoblastic Leukemia
MYB-TYK2 fusion
B Acute Lymphoblastic Leukemia
vorinostat + BMS-722782
Sensitive: D – Preclinical
vorinostat + BMS-722782
Sensitive
:
D
vorinostat + BMS-722782
Sensitive: D – Preclinical
vorinostat + BMS-722782
Sensitive
:
D
MYB-TYK2 fusion
B Acute Lymphoblastic Leukemia
MYB-TYK2 fusion
B Acute Lymphoblastic Leukemia
vorinostat + ALXN2075
Sensitive: D – Preclinical
vorinostat + ALXN2075
Sensitive
:
D
vorinostat + ALXN2075
Sensitive: D – Preclinical
vorinostat + ALXN2075
Sensitive
:
D
CDH1 deletion
Breast Cancer
CDH1 deletion
Breast Cancer
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
CDH1 deletion
Gastric Cancer
CDH1 deletion
Gastric Cancer
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
vorinostat
Sensitive: D – Preclinical
vorinostat
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login